Genes Modulating Butyrate Metabolism for Assessing Clinical Prognosis and Responses to Systematic Therapies in Hepatocellular Carcinoma

Genes Modulating Butyrate Metabolism for Assessing Clinical Prognosis and Responses to Systematic Therapies in Hepatocellular Carcinoma

Butyrate, one of the major products of the gut microbiota, has played notable roles in diverse therapies for multiple tumors. Our study aimed to determine the roles of genes that modulate butyrate metabolism (BM) in predicting the clinical prognosis and responses to systemic therapies in hepatocellu...

Full description

Bibliographic Details
Main Authors: Zhao Chuanbing, Zhang Zhengle, Ding Ruili, Zhu Kongfan, Tao Jing
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomolecules
Subjects:
hepatocellular carcinoma
butyrate metabolism
prognosis
immunotherapy
drug sensitivity
TACE
Online Access:https://www.mdpi.com/2218-273X/13/1/52

Internet

https://www.mdpi.com/2218-273X/13/1/52

Similar Items